Compare Stocks: NSTM, PPBT, ABP, and SCNI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABP Abpro	$0.52	$0.52	$0.52 ▼ $29.97	$1.42M	N/A	5.06 million shs	N/A
NSTM NovelStem International	$0.01	$0.01	$0.01 ▼ $0.04	$470K	2.47	26,436 shs	8,950 shs
PPBT Purple Biotech	$1.75	$1.56	$1.16 ▼ $14.10	$1.63M	0.71	3.98 million shs	340,923 shs
SCNI Scinai Immunotherapeutics	$1.86	$2.54	$1.85 ▼ $16.40	$1.31M	2.08	167,786 shs	82,384 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABP Abpro	0.00%	0.00%	0.00%	0.00%	-91.91%
NSTM NovelStem International	0.00%	0.00%	-17.10%	-69.35%	-47.22%
PPBT Purple Biotech	0.00%	+4.17%	+22.38%	-40.07%	-73.48%
SCNI Scinai Immunotherapeutics	0.00%	-25.90%	-24.17%	-54.37%	-87.60%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABP Abpro	$0.52	$0.52	$0.52 ▼ $29.97	$1.42M	N/A	5.06 million shs	N/A
NSTM NovelStem International	$0.01	$0.01	$0.01 ▼ $0.04	$470K	2.47	26,436 shs	8,950 shs
PPBT Purple Biotech	$1.75	$1.56	$1.16 ▼ $14.10	$1.63M	0.71	3.98 million shs	340,923 shs
SCNI Scinai Immunotherapeutics	$1.86	$2.54	$1.85 ▼ $16.40	$1.31M	2.08	167,786 shs	82,384 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABP Abpro	0.00%	0.00%	0.00%	0.00%	-91.91%
NSTM NovelStem International	0.00%	0.00%	-17.10%	-69.35%	-47.22%
PPBT Purple Biotech	0.00%	+4.17%	+22.38%	-40.07%	-73.48%
SCNI Scinai Immunotherapeutics	0.00%	-25.90%	-24.17%	-54.37%	-87.60%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABP Abpro	1.50	Reduce	N/A	N/A
NSTM NovelStem International	0.00	N/A	N/A	N/A
PPBT Purple Biotech	2.00	Hold	$30.00	1,614.29% Upside
SCNI Scinai Immunotherapeutics	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest NSTM, PPBT, ABP, and SCNI Analyst Ratings

Date	Company	Brokerage	Action	Rating
8/31/2026	PPBT Purple Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
8/17/2026	PPBT Purple Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
8/3/2026	PPBT Purple Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
7/17/2026	SCNI Scinai Immunotherapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/16/2026	PPBT Purple Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
6/26/2026	PPBT Purple Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
6/11/2026	PPBT Purple Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)

(Data available from 9/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABP Abpro	N/A	N/A	N/A	N/A	($8.83) per share	N/A
NSTM NovelStem International	$10K	46.86	$0.05 per share	0.18	($0.05) per share	-0.19
PPBT Purple Biotech	N/A	N/A	N/A	N/A	$10.39 per share	N/A
SCNI Scinai Immunotherapeutics	$1.31M	1.01	N/A	N/A	$7.77 per share	0.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABP Abpro	-$7.23M	-$4.23	N/A	N/A	N/A	N/A	N/A	-344.76%	N/A
NSTM NovelStem International	$2.38M	N/A	N/A	N/A	N/A	N/A	-124.84%	-275.18%	N/A
PPBT Purple Biotech	-$26.39M	-$23.25	N/A	N/A	N/A	N/A	-147.77%	-111.59%	11/13/2026 (Estimated)
SCNI Scinai Immunotherapeutics	-$8.31M	-$95.34	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest NSTM, PPBT, ABP, and SCNI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/7/2026	Q2 2026	PPBT Purple Biotech	-$0.98	$1.07	+$2.05	-$0.40	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABP Abpro	N/A	N/A	N/A	N/A	N/A
NSTM NovelStem International	N/A	N/A	N/A	N/A	N/A
PPBT Purple Biotech	N/A	N/A	N/A	N/A	N/A
SCNI Scinai Immunotherapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABP Abpro	N/A	0.07	0.07
NSTM NovelStem International	N/A	0.03	0.03
PPBT Purple Biotech	N/A	3.70	3.70
SCNI Scinai Immunotherapeutics	0.05	1.56	1.35

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABP Abpro	23.30%
NSTM NovelStem International	N/A
PPBT Purple Biotech	9.64%
SCNI Scinai Immunotherapeutics	58.41%

Insider Ownership

Company	Insider Ownership
ABP Abpro	13.70%
NSTM NovelStem International	13.64%
PPBT Purple Biotech	2.98%
SCNI Scinai Immunotherapeutics	6.03%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABP Abpro	15	2.72 million	2.34 million	N/A
NSTM NovelStem International	15	49.33 million	42.60 million	Not Optionable
PPBT Purple Biotech	20	930,000	901,000	Optionable
SCNI Scinai Immunotherapeutics	20	710,000	664,000	Not Optionable

NSTM, PPBT, ABP, and SCNI Headlines

Recent News About These Companies

Scinai Immunotherapeutics Ltd. (SCNI) Q2 2026 Earnings Call Transcript

August 26, 2026 | seekingalpha.com

Scinai Immunotherapeutics Ltd (SCNI) Stock Price, Quote, News & History

August 25, 2026 | benzinga.com

Scinai Immunotherapeutics Ltd.: Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum

August 24, 2026 | finanznachrichten.de

Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum

August 24, 2026 | prnewswire.com

Scinai Immunotherapeutics Ltd. Sponsored ADR

August 14, 2026 | edition.cnn.com

Scinai Immunotherapeutics Ltd.: Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration

August 10, 2026 | finanznachrichten.de

Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration

August 10, 2026 | prnewswire.com

Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives

June 10, 2026 | prnewswire.com

Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility

May 20, 2026 | prnewswire.com

Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe

May 15, 2026 | prnewswire.com

Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

April 24, 2026 | prnewswire.com

Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities

April 6, 2026 | prnewswire.com

Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration

April 1, 2026 | prnewswire.com

Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026

March 19, 2026 | prnewswire.com

Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price

March 16, 2026 | prnewswire.com

Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept

March 2, 2026 | prnewswire.com

Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform

February 25, 2026 | prnewswire.com

Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm

February 17, 2026 | prnewswire.com

Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL

January 7, 2026 | prnewswire.com

Scinai Immunotherapeutics Ltd. Sponsored ADR (NASDAQ:SCNI) Sees Large Drop in Short Interest

January 2, 2026 | defenseworld.netD

Media Sentiment Over Time

NSTM, PPBT, ABP, and SCNI Company Descriptions

Abpro NASDAQ:ABP

$0.52 0.00 (0.00%)

As of 09/4/2026

Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

NovelStem International OTCMKTS:NSTM

$0.0095 0.00 (0.00%)

As of 09/4/2026 02:39 PM Eastern

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.

Purple Biotech NASDAQ:PPBT

$1.75 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.

Scinai Immunotherapeutics NASDAQ:SCNI

$1.86 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NSTM, PPBT, ABP, and SCNI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NSTM, PPBT, ABP, and SCNI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NSTM, PPBT, ABP, and SCNI Headlines

Recent News About These Companies

Media Sentiment Over Time

NSTM, PPBT, ABP, and SCNI Company Descriptions

Abpro NASDAQ:ABP

NovelStem International OTCMKTS:NSTM

Purple Biotech NASDAQ:PPBT

Scinai Immunotherapeutics NASDAQ:SCNI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NSTM, PPBT, ABP, and SCNI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NSTM, PPBT, ABP, and SCNI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NSTM, PPBT, ABP, and SCNI Headlines

Recent News About These Companies

Media Sentiment Over Time

NSTM, PPBT, ABP, and SCNI Company Descriptions

Abpro NASDAQ:ABP

NovelStem International OTCMKTS:NSTM

Purple Biotech NASDAQ:PPBT

Scinai Immunotherapeutics NASDAQ:SCNI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools